Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...

PTC PTC underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Get a deeper insight into the potential performance of PTC Inc. (PTC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for ...

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

The long-awaited Bunyoro University (BU) in Hoima district remains stalled due to political interference, blackmail and ...

Stocks extended their gains on Tuesday on strength in megacap technology stocks. Stocks moved higher Tuesday despite the US imposing a 10% tariff on Chinese goods.  China retaliated immediately and ...

Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...

PTC Therapeutics (PTCT) shares rallied 9% in the last trading session to close at $50.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

PointCast Solutions were developed to counter the high costs, inefficiencies, and delays of traditional VSAT deployment and ...